Fux CA, Costerton JW, Stewart PS, Stoodley P: Survival strategies of AZD8931 infectious biofilms. Trends Microbiol 2005, 13:34–40.PubMedCrossRef 11. Olson ME, Ceri H, Morck DW, Buret AG, Read RR: Biofilm bacteria: formation and comparative susceptibility AG-014699 molecular weight to antibiotics. Can J Vet Res 2002, 66:86–92.PubMed 12. Miller MB, Bassler BL: Quorum sensing in bacteria. Annu Rev Microbiol 2001, 55:165–199.PubMedCrossRef 13. Hentzer M, Wu

H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, et al.: Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 2003, 22:3803–3815.PubMedCrossRef 14. Hume EB, Baveja J, Muir B, Schubert TL, Kumar N, Kjelleberg S, et al.: The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones. Biomaterials 2004, 25:5023–5030.PubMedCrossRef 15. Anguita-Alonso P, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Saba V, et al.: RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob Agents Chemother 2007, 51:2594–2596.PubMedCrossRef 16. Kroes I, Lepp PW, Relman DA: Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci USA 1999, 96:14547–14552.PubMedCrossRef 17. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE: Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005, 43:5721–5732.PubMedCrossRef

18. Paster BJ, Boches SK, Galvin JL, Ericson RE, Lau CN, Levanos VA, et al.: Bacterial diversity in human subgingival plaque. J Bacteriol 2001, 183:3770–3783.PubMedCrossRef 19. Ajdic D, McShan WM, McLaughlin RE, Savic G, Chang J, Carson MB, et al.: Genome sequence Bindarit price of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci USA 2002, 99:14434–14439.PubMedCrossRef 20. Diaz PI, Chalmers NI, Rickard AH, Kong C, Milburn CL, Palmer RJ Jr, et al.: Molecular characterization of subject-specific oral microflora during initial colonization of enamel. Appl Environ Microbiol 2006, 72:2837–2848.PubMedCrossRef 21. Hamada S, Slade HD: Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 1980, 44:331–384.PubMed

from 22. Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986, 50:353–380.PubMed 23. Mitchell TJ: The pathogenesis of streptococcal infections: from tooth decay to meningitis. Nat Rev Microbiol 2003, 1:219–230.PubMedCrossRef 24. Reichenbach H: The ecology of the myxobacteria. Environ Microbiol 1999, 1:15–21.PubMedCrossRef 25. Schneiker S, Perlova O, Kaiser O, Gerth K, Alici A, Altmeyer MO, et al.: Complete genome sequence of the myxobacterium Sorangium cellulosum. Nat Biotechnol 2007, 25:1281–1289.PubMedCrossRef 26. Reichenbach H: Myxobacteria, producers of novel bioactive substances. J Ind Microbiol Biotechnol 2001, 27:149–156.PubMedCrossRef 27. Reichenbach H, Hofle G: Discovery and development of the epothilones: a novel class of antineoplastic drugs. Drugs R D 2008, 9:1–10.